Galderma Group AG (CHIX:GALDZ) Interest Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:GALDZ Galderma Group AG CHIX:GALDZ
18 GF Score
Price CHF159.98
View Full Analysis

What is Galderma Group AG Interest Received?

Interest Received only applicable to companies reporting Cash Flow from Operations in direct method.

CHIX:GALDZ
18GF Score
Galderma Group AG CHIX:GALDZ
Interest Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Galderma Group AG Business Description

Address Zahlerweg 10, Zug, CHE, 6300
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a stand-alone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 40% of net sales from the US and employs more than 7,500 people.
18GF Score

Get the complete analysis for CHIX:GALDZ

Interest Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF159.98
Price